Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.26 USD | +0.62% | +13.79% | +12.93% |
16/04 | BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating | MT |
09/04 | Xencor Names Bart Cornelissen as Chief Financial Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.93% | 1.49B | |
+8.49% | 105B | |
-1.18% | 104B | |
+5.79% | 22.94B | |
-12.66% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.43% | 16.96B | |
+8.05% | 14.16B | |
+38.95% | 12.63B |
- Stock Market
- Equities
- XNCR Stock
- News Xencor, Inc.
- Xencor : to Receive Royalties on Worldwide Sales of Vir, GlaxoSmithKline COVID-19 Drug Following FDA Emergency Use OK